Spaulding Rehabilitation Hospital at Harvard Medical School and Highland Instruments, Inc., Jointly Announce Release of ALGEA 2 Clinical Trial Results
Spaulding Principal Investigator, Felipe Fregni, MD, PhD, MMSc, MPH, MEd, stated "We have seen great results with ESStim™ across the chronic pain and movement disorder indications.